In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

CRISPR 2.0 Summit

Nov 16, 2021 - 08:00 AM - Nov 18, 05:15 PM
Hanson Wade

ZIP: 00000
Phone: +16174554188

Ticket Price: USD 1599.0 - USD 1999.0

CRISPR is one of the most powerful discoveries of the last decade, and we are now heralding in the era of gene editing.

In the time since its discovery, CRISPR has rapidly become an established tool in the genomics toolbox. Now the question is: What next?

The CRISPR 2.0 Summit is devoted to showcasing only the latest and greatest innovations by uncovering how the next generation of CRISPR tools are radically enhancing efficacy, minimizing off-target effects and enabling efficient delivery to specific tissues to ensure you stay at the forefront of this rapidly exploding field.

Discover the promise of novel Cas variants, base and prime editing approaches, innovative delivery mechanisms, and the applications of these next generation tools through learnings from CRISPR clinical trials and new and unpublished data.

Don't get left behind. Join 100+ leading pharma and biotech companies pioneering CRISPR-based therapeutics into the clinic to usher in the next generation of safe, targeted and effective genome editing.

Brochure: https://go.evvnt.com/816308-0?pid=1052
Tickets: https://go.evvnt.com/816308-1?pid=1052

Conference Only (1st Release - Pay by July 30): USD 1599.0,
Conference Only (2nd Release - Pay by August 27): USD 1699.0,
Conference Only (3rd Release - Pay by September 24): USD 1799.0,
Conference Only (4th Release - Pay by October 22): USD 1899.0,
Conference Only (Standard Rate): USD 1999.0

Speaker Details

John Murphy, Chief Scientific Officer, Arbor Biotechnologies, Roy Ziblat, Scientific Manager, Arbor Biotechnologies, Marco Weinberg, Vice President, Research and Development, AskBio, Roberto Nitsch, Director, AstraZeneca, Joseph Miano, J. Harold Harrison, MD, Distinguished University Chair in Vascular Biology, Augusta University, Jacob Layer, Senior Scientist, Group Leader, eGenesis Bio, Pankaj Mandal, Senior Staff Fellow, Office of Tissues and Advanced Therapies, Division of Cellular and Gene Therapies, FDA/CBER, Kalina Paunovska, Postdoctoral Scholars, Georgia Institute of Technology, Dahlman Lab, Danilo Maddalo, Senior Scientist, Genentech, Beeke Wienert, Senior Scientist, Research, Graphite Bio, Danny Dever, Head of Discovery Research, Graphite Bio, Jane Grogan, Chief Scientific Officer, Graphite Bio, Ben Kleinstiver, Assistant Professor, Harvard Medical School and Mass General Hospital, Sean Burns, Vice President, Disease Biology, Intellia Therapeutics, Triparna Sen, Assistant Attending, Memorial Sloan Kettering Cancer Center, Gregory Cost, Senior Director of Biology, Metagenomi, Jyun-Liang "Aaron" Lin, Scientist II, Metagenomi, Andrew Anzalone, Head of Prime Editing Platforms, Prime Medicine, Brett Staahl, Vice President Platform, Co- Founder, Scribe Therapeutics, Niren Murthy, Professor, Bioengineering, University of California at Berkeley

Event Categories
Keywords: pharmaceutical


Events Calendar

31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4

Event Location


VIP Life Time Subscription to our Newsletters!